| Mentari Therapeutics | | $200.0M | | Jul 24, 2026 |
| Cheiron launches $8 million seed | seed | $8.0M | | Jul 23, 2026 |
| Elle MD | | $1.1M | | Jul 23, 2026 |
| Agricultural biotech firm Moa Technology | series c | $22.2M | Oxford Science EnterprisesSupernova | Jul 23, 2026 |
| SK Networks-Backed AI Drug Discovery Startup Phoenix Lab | seed | $8.0M | | Jul 23, 2026 |
| Crystalys Therapeutics | series b | $130.0M | Frazier Life Sciences | Jul 22, 2026 |
| Transcripta Bio | series a | $24.0M | | Jul 22, 2026 |
| Brenus Pharma | series a ext | $11.0M | | Jul 21, 2026 |
| Rege Nephro | | $10.6M | | Jul 21, 2026 |
| Estrigenix Therapeutics | seed | $2.0M | | Jul 21, 2026 |
| Cyllene Therapeutics | series c | $33.0M | | Jul 20, 2026 |
| Cyllene Therapeutics | series c | $33.0M | | Jul 20, 2026 |
| Healome Therapeutics | seed | $2.0M | | Jul 17, 2026 |
| Sightera Biosciences | pre seed | $3.0M | Entourage | Jul 17, 2026 |
| Reversing AI drug discovery: Belgian biotech Sightera | | $3.0M | | Jul 17, 2026 |
| Antwerp’s Sightera Biosciences | pre seed | $3.0M | Entourage | Jul 17, 2026 |
| Endo Tools Therapeutics | series c | $23.0M | | Jul 16, 2026 |
| Danish biotech startup Visibuilt | seed | $3.3M | EIFOUnconventional VenturesProptechfonden | Jul 16, 2026 |
| Medtronic | | $650.0M | | Jul 16, 2026 |
| designer | series c | $400.0M | | Jul 15, 2026 |
| AdvanCell | series d | $315.0M | Alpha Wave | Jul 15, 2026 |
| Sapphiros | | $12.4M | | Jul 15, 2026 |
| ARCHIMED Successfully | | $1.1B | | Jul 15, 2026 |
| Mighty Therapeutics | | $150.0M | | Jul 14, 2026 |
| Draig | series b | $65.0M | | Jul 14, 2026 |
| Spero Therapeutics | | $105.0M | Utebzi Milestones And Royalties <p>Spero Therapeutics | Jul 14, 2026 |
| Edgewise Therapeutics | | $2.6B | | Jul 14, 2026 |
| Draig Therapeutics | series b | $65.0M | Janus Henderson InvestorsMarshall WaceBritish Business Bank+7 | Jul 14, 2026 |
| Mycelium-based paving material developer Visibuilt | seed | $3.3M | EIFOUnconventional Ventures followed by Proptechfonden and backed again by earlier | Jul 13, 2026 |
| MindRank | series b | $52.0M | | Jul 12, 2026 |
| Octozi | seed | $3.0M | Remarkable Ventures | Jul 11, 2026 |
| St. Louis biotech | | $35.0M | | Jul 10, 2026 |
| En Carta Diagnostics | | $5.0M | Blue Forest Ventures | Jul 10, 2026 |
| FORE Biotherapeutics | series d | $67.4M | | Jul 10, 2026 |
| Alchemab Therapeutics | series a | $29.3M | | Jul 9, 2026 |
| London’s Alchemab Therapeutics | series a | $29.3M | | Jul 9, 2026 |
| Alchemab | series a | $25.0M | | Jul 9, 2026 |
| MacroGenics | | $122.5M | | Jul 9, 2026 |
| Allotera Therapeutics | debt | $35.0M | | Jul 8, 2026 |
| Cyllene Therapeutics | series c | $33.0M | GordonMD Global | Jul 8, 2026 |
| Healome Therapeutics | seed | $2.0M | Empirical Ventures | Jul 7, 2026 |
| Cyllene Therapeutics (formerly known as EG 427) | series c | $33.0M | | Jul 7, 2026 |
| Katalyze AI | | $10.5M | | Jul 6, 2026 |
| Graph AI In Talks To | series a | $14.0M | | Jul 6, 2026 |
| Epitome Therapeutics | pre seed | $4.0M | | Jul 6, 2026 |
| Respiratory biotech Celea | | $180.0M | | Jul 3, 2026 |
| ALP Bio | | $161.0K | | Jul 3, 2026 |
| Celea Therapeutics | | $180.0M | | Jul 2, 2026 |
| Eli Lilly acquisition payday fuels $1M seed | seed | $1.0M | | Jul 2, 2026 |
| Telum Therapeutics | series a | $18.0M | | Jul 1, 2026 |